1. Home
  2. IPHA vs DUOT Comparison

IPHA vs DUOT Comparison

Compare IPHA & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.96

Market Cap

174.2M

Sector

Health Care

ML Signal

HOLD

Logo Duos Technologies Group Inc.

DUOT

Duos Technologies Group Inc.

HOLD

Current Price

$9.80

Market Cap

180.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPHA
DUOT
Founded
1999
1990
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
174.2M
180.9M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IPHA
DUOT
Price
$1.96
$9.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$5.00
$12.75
AVG Volume (30 Days)
565.0K
313.0K
Earning Date
09-17-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,839,695.00
$19,026,308.00
Revenue This Year
$22.29
$292.26
Revenue Next Year
$43.90
$43.21
P/E Ratio
N/A
N/A
Revenue Growth
N/A
159.00
52 Week Low
$1.43
$3.84
52 Week High
$3.51
$11.23

Technical Indicators

Market Signals
Indicator
IPHA
DUOT
Relative Strength Index (RSI) 50.64 52.50
Support Level $1.85 $9.74
Resistance Level $2.01 $11.20
Average True Range (ATR) 0.08 0.64
MACD 0.01 0.05
Stochastic Oscillator 69.64 54.69

Price Performance

Historical Comparison
IPHA
DUOT

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: